Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab plus Chemotherapy Followed by Surgery for Advanced Thymoma or Thymic Carcinoma
NCT01025089Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2009
- Primary completion
- Dec 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in thymoma, thymic carcinoma (TC), sponsored by Memorial Sloan Kettering Cancer Center. Started Dec 2009; status: active, not recruiting.
02
Drugs
KL-140
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT01025089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025089.